41 In 5,145 overweight/obese people with T2DM (mean age 58.7 years, diabetes duration five years, BMI 36 kg/m 2 ) there was no difference in the rate of CV events or HF development over a median follow-up duration of 9.6 years, 41 despite greater weight loss (8.6% vs
It's the only way to engage with it and learn to manage it)
Pharmacodynamics/Pharmacokinetics: L-Carnitine (Carnicor) indirectly regulates glucose (G) utilization thru control of acetyl CoA/CoA ratio, an important regulator of pyruvate dehydrogenase (PDH) activity and consequent acetyl CoA formation which enters the TCA cycle and releases energy
Some clinics also provide financing options to make treatment more accessible
Nauck MA, Kahle M, Baranov O, Deacon CF, Holst JJ
The most compelling campaigns anchor messaging in real-world outcomes: For HCPs, the story starts with data cardiovascular risk reduction, sustained weight loss, lower A1C, and improved patient vitality which drive practice change and position these therapies as more than metabolic tools